A decision is expected in the fourth quarter of 2025.

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

A new generation of oral weight loss medications could transform the fight against obesity and diabetes in low- and ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Health service to make medications Mounjaro and Wegovy available after short consultation as part of war on obesity ...